JESSICA GORSEK: Open Payments
NPI 1720468507 · SPRINGFIELD, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,340 in 122 payments from 29 companies in 2025. Trend: 2023 $1,101 · 2024 $1,966 · 2025 $2,340
Food & beverage: $2,340
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 28 | $390 |
| Neurocrine BioSciences, Inc. | 10 | $180 |
| Novartis Pharmaceuticals Corporation | 9 | $176 |
| TG Therapeutics, Inc. | 13 | $149 |
| SK Life Science, Inc. | 5 | $128 |
| LivaNova USA, Inc. | 4 | $115 |
| Alexion Pharmaceuticals, Inc. | 6 | $99 |
| GENZYME CORPORATION | 3 | $99 |
| Neurelis, Inc. | 5 | $93 |
| Biogen, Inc. | 4 | $91 |
Products named: QULIPTA, INGREZZA, LEQVIO, BRIUMVI, UBRELVY, VNS THERAPY SENTIVA MODEL 1000 GENERATOR, ULTOMIRIS, VALTOCO.
Industry payments across IL — which companies pay providers there.
